Featured Articles

31. Building Strategic Partnerships Between IP Law Firms And Biopharma 3/4/2026

    Patent attorney Eric M. Brusca, Ph.D., explains how biopharmaceutical companies and their IP law firms can cultivate relationships that drive meaningful business value.

32. Where Are They Now? Life Science Cares 2/27/2026

    Life Science Cares, an industry philanthropic organization, turns 10 in April. Now in five cities and Switzerland, the organization remains focused on fighting poverty.

33. Life Sciences Hubs Creating More Opportunity For Startups And Investors 2/26/2026

    Life sciences hubs beyond Boston and the Bay Area are giving startups new opportunities to grow and scale their businesses, writes Mike Carnes at NCBiotech.

34. How Strategic Collaborations Can Accelerate Innovation And Create Value 2/24/2026

    Platform biotechs should aim for partnerships that compound value over time, beyond a simple funding mechanism, writes Unnatural Products CEO Cameron Pye, Ph.D.  

35. Time Is Lives: How Collaboration And Urgency Are Rewriting The Future Of Rare Disease 2/19/2026

    The inflection point has arrived, says Rob Freishtat, MD, MPH. Understand how collaboration will rewrite how we think of rare disease clinical research.

36. Activate These Three Levers To Create A More Effective Workforce 2/13/2026

    A convergence of market forces will push life sciences employers to rethink their workforce strategies and reimagine how work gets done, writes Ruby van den Hoff.

37. Why Human Leadership Matters More Than Ever In The AI Era 2/10/2026

    In the AI era, thriving life sciences organizations will differentiate themselves based on their ability to combine AI's power with distinctly human capabilities, writes Christine Ann Miller.

38. Policy Matters: The Reauthorized Rare Pediatric Disease Voucher Program 2/5/2026

    Congress finally reauthorized the Rare Pediatric Disease Priority Review Voucher program, after it expired in 2024. That matters a lot to patients and drug developers, writes George Magrath, M.D. 

39. On The Road: The Business Of Biotech In San Francisco For JPM2026 2/3/2026

    The Business of Biotech was back in San Francisco for JPM in January, and offers here a few observations, highlights, and reportage from a selection of interviews, events, and company presentations.

40. Thinking Small: A Counterintuitive Strategy For Biopharma Startups 2/2/2026

    There is more than one way to blockbuster product sales, and sometimes smaller might be better, writes Bennett Smith.